KFDA to reclassify 500 medicines

Published: 2012-02-23 06:59:00

Updated: 2012-02-23 06:59:00

The Korea Food & Drug Association (KFDA) said Tuesday that it has nearly completed the re-classification of all 6,630 drugs as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitoring of drug use.

Among them, the number of re-categorized medicines is estima...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK